Advanced search
Publication Cover
Expert Review of Anti-infective Therapy Volume 2, 2004 - Issue 1
Submit an article Journal homepage
33
Views
12
CrossRef citations to date
0
Altmetric
Drug Evaluation

Peginterferon-α2b and ribavirin

Joseph Ahn Department of Medicine, Northwestern University Medical School Northwestern Memorial Hospital, Chicago, Illinois 60611, USA. [email protected]
&
Steven Flamm Department of Medicine, Northwestern University Medical School Northwestern Memorial Hospital, Chicago, Illinois 60611, USA. [email protected]
Pages 17-25 | Published online: 10 Jan 2014

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Josep Mallolas & Montserrat Laguno. (2008) Pegylated IFN-α2b plus ribavirin for treatment-naive patients coinfected with HCV and HIV. Expert Review of Anti-infective Therapy 6:3, pages 281-289.
Read now
Mingjun Huang & Milind Deshpande. (2004) Hepatitis C drug discovery: in vitro and in vivo systems and drugs in the pipeline. Expert Review of Anti-infective Therapy 2:3, pages 375-388.
Read now

Articles from other publishers (10)

Cornelia B. Landersdorfer, Suzanne M. Caliph, David M. Shackleford, David B. Ascher & Lisa M. Kaminskas. (2015) PEGylated Interferon Displays Differences in Plasma Clearance and Bioavailability Between Male and Female Mice and Between Female Immunocompetent C57Bl/6J and Athymic Nude Mice. Journal of Pharmaceutical Sciences 104:5, pages 1848-1855.
Crossref
Allison Salk, Derrick J Stobaugh, Parakkal Deepak & Eli D Ehrenpreis. (2013) Ischemic Colitis with Type I Interferons Used in the Treatment of Hepatitis C and Multiple Sclerosis: An Evaluation from the Food and Drug Administration Adverse Event Reporting System and Review of the Literature. Annals of Pharmacotherapy 47:4, pages 537-542.
Crossref
L.M.R. El-Attar, C.D. Partidos & C.R. Howard. (2010) A peptide mimotope of hepatitis C virus E2 protein is immunogenic in mice and block human anti-HCV sera. Journal of Medical Virology 82:10, pages 1655-1665.
Crossref
Andrew J. Muir, Mitchell L. Shiffman, Atif Zaman, Boris Yoffe, Andrew de la Torre, Steven Flamm, Stuart C. Gordon, Paul Marotta, John M. Vierling, Juan Carlos Lopez-Talavera, Kelly Byrnes-Blake, David Fontana, Jeremy Freeman, Todd Gray, Diana Hausman, Naomi N. Hunder & Eric Lawitz. (2010) Phase 1b study of pegylated interferon lambda 1 with or without ribavirin in patients with chronic genotype 1 hepatitis C virus infection. Hepatology 52:3, pages 822-832.
Crossref
P. Gerner & S. Wirth. (2009) Hepatitis B und C im KindesalterHepatitis B and C in childhood. Monatsschrift Kinderheilkunde 157:2, pages 177-188.
Crossref
Ursula Plöckinger, Denny Krüger, Alexandra Bergk, Viola Weich, Bertram Wiedenmann & Thomas Berg. (2007) Hepatitis-C Patients Have Reduced Growth Hormone (GH) Secretion Which Improves During Long-Term Therapy With Pegylated Interferon-α. The American Journal of Gastroenterology 102:12, pages 2724-2731.
Crossref
Daniel X. JohanssonCécile Voisset, Alexander W. Tarr, Mie Aung, Jonathan K. Ball, Jean Dubuisson & Mats A. A. Persson. (2007) Human combinatorial libraries yield rare antibodies that broadly neutralize hepatitis C virus. Proceedings of the National Academy of Sciences 104:41, pages 16269-16274.
Crossref
Claude Souvignet, Olivier Lejeune & Christian Trepo. (2007) Interferon-based treatment of chronic hepatitis C. Biochimie 89:6-7, pages 894-898.
Crossref
Patrick Gerner. 2007. Pediatric Infectious Diseases Revisited. Pediatric Infectious Diseases Revisited 391 404 .
Marija Simin, Jesper Brok, Davor Stimac, Christian Gluud & Lise Lotte Gluud. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.